tetano
Editor, Senior Moderator
Thromb Res
. 2021 Dec 7;S0049-3848(21)00556-9.
doi: 10.1016/j.thromres.2021.12.003. Online ahead of print.
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
Farid Rashidi[SUP] 1 [/SUP], Stefano Barco[SUP] 2 [/SUP], Parisa Rezaeifar[SUP] 3 [/SUP], Parham Sadeghipour[SUP] 4 [/SUP], Samad Ghodrati[SUP] 5 [/SUP], Hooman Bakhshandeh[SUP] 6 [/SUP], Seyed Ali Mousavi-Aghdas[SUP] 3 [/SUP], Armin Sadeghi[SUP] 3 [/SUP], Akbar Sharifi[SUP] 3 [/SUP], Hamed Valizadeh[SUP] 3 [/SUP], Haleh Mikaeili[SUP] 3 [/SUP], Farnaz Rafiee[SUP] 7 [/SUP], Zahar Navarbaf[SUP] 3 [/SUP], Gita Farajian[SUP] 5 [/SUP], Behnood Bikdeli[SUP] 8 [/SUP], Khalil Ansarin[SUP] 3 [/SUP], Ata Mahmoodpoor[SUP] 9 [/SUP]
Affiliations
No abstract availableKeywords: Acute respiratory distress syndrome (ARDS); Anticoagulation; Coronavirus disease 2019 (COVID-19); Fibrinolytic therapy; Tissue plasminogen activator (tPA).
. 2021 Dec 7;S0049-3848(21)00556-9.
doi: 10.1016/j.thromres.2021.12.003. Online ahead of print.
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
Farid Rashidi[SUP] 1 [/SUP], Stefano Barco[SUP] 2 [/SUP], Parisa Rezaeifar[SUP] 3 [/SUP], Parham Sadeghipour[SUP] 4 [/SUP], Samad Ghodrati[SUP] 5 [/SUP], Hooman Bakhshandeh[SUP] 6 [/SUP], Seyed Ali Mousavi-Aghdas[SUP] 3 [/SUP], Armin Sadeghi[SUP] 3 [/SUP], Akbar Sharifi[SUP] 3 [/SUP], Hamed Valizadeh[SUP] 3 [/SUP], Haleh Mikaeili[SUP] 3 [/SUP], Farnaz Rafiee[SUP] 7 [/SUP], Zahar Navarbaf[SUP] 3 [/SUP], Gita Farajian[SUP] 5 [/SUP], Behnood Bikdeli[SUP] 8 [/SUP], Khalil Ansarin[SUP] 3 [/SUP], Ata Mahmoodpoor[SUP] 9 [/SUP]
Affiliations
- PMID: 34969528
- DOI: 10.1016/j.thromres.2021.12.003
No abstract availableKeywords: Acute respiratory distress syndrome (ARDS); Anticoagulation; Coronavirus disease 2019 (COVID-19); Fibrinolytic therapy; Tissue plasminogen activator (tPA).